|
1
|
Wu J, Hsieh MY, Wang Y, Roberts E, Vallejo
D, Lee A and Ermel R: Antitumor properties of ouabain in lipid
double emulsion in orthotopic canine osteosarcoma xenografted mouse
model. Cancer Res. 74:54122014. View Article : Google Scholar
|
|
2
|
Roos A, Yustein JT and Donehower L:
Oncogenic role of Runx2 in the development of osteosarcoma. Cancer
Res. 73:5036. 2013. View Article : Google Scholar
|
|
3
|
Pompetti F, Rizzo P, Simon RM, Freidlin B,
Mew DJ, Pass HI, Picci P, Levine AS and Carbone M: Oncogene
alterations in primary, recurrent, and metastatic human bone
tumors. J Cell Biochem. 63:37–50. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oda Y, Naka T, Takeshita M, Iwamoto Y and
Tsuneyoshi M: Comparison of histological changes and changes in
nm23 and c-MET expression between primary and metastatic sites in
osteosarcoma: A clinicopathologic and immunohistochemical study.
Human Pathol. 31:709–716. 2000. View Article : Google Scholar
|
|
5
|
Liang S, Ren Z, Han X, Yang J, Shan L, Li
L, Wang B, Zhang Q, Mu T, Chen K, et al: PLA2G16 expression in
human osteosarcoma is associated with pulmonary metastasis and poor
prognosis. PLoS One. 10:e01272362015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hughes DP: How the NOTCH pathway
contributes to the ability of osteosarcoma cells to
metastasizePediatric and Adolescent Osteosarcoma. Jaffe N, Bruland
OS and Bielack S: 152. Springer; New York, NY: pp. 479–496. 2010,
View Article : Google Scholar
|
|
7
|
Casar B, Rimann I, Kato H, Shattil SJ,
Quigley JP and Deryugina EI: In vivo cleaved CDCP1 promotes early
tumor dissemination via complexing with activated β1 integrin and
induction of FAK/PI3K/Akt motility signaling. Oncogene. 33:255–268.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim LC, Song L and Haura EB: Src kinases
as therapeutic targets for cancer. Nat Rev Clin Oncol. 6:587–595.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rubin EM, Guo Y, Tu K, Xie J, Zi X and
Hoang BH: Wnt inhibitory factor 1 decreases tumorigenesis and
metastasis in osteosarcoma. Mol Cancer Ther. 9:731–741. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krishnan K, Khanna C and Helman LJ: The
biology of metastases in pediatric sarcomas. Cancer J. 11:306–313.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eccles SA and Welch DR: Metastasis: Recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Diao CY, Guo HB, Ouyang YR, Zhang HC, Liu
LH, Bu J, Wang ZH and Xiao T: Screening for metastatic osteosarcoma
biomarkers with a DNA microarray. Asian Pac J Cancer Prev.
15:1817–1822. 2013. View Article : Google Scholar
|
|
15
|
Smyth GK: Limma: Linear models for
microarray dataBioinformatics and computational biology solutions
using R and Bioconductor. Gentleman R, Carey VJ, Huber W, Irizarry
RA and Dudoit S: Springer; New York: pp. 397–420. 2005, View Article : Google Scholar
|
|
16
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene Ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nepusz T, Yu H and Paccanaro A: Detecting
overlapping protein complexes in protein-protein interaction
networks. Nat Methods. 9:471–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
da Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2008. View Article : Google Scholar
|
|
21
|
da Huang W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meyer LR, Zweig AS, Hinrichs AS, Karolchik
D, Kuhn RM, Wong M, Sloan CA, Rosenbloom KR, Roe G, Rhead B, et al:
The UCSC Genome Browser database: Extensions and updates 2013.
Nucleic Acids Res. 41:(Database issue). D64–D69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
PosthumaDeBoer J, Witlox MA, Kaspers GJ
and Van Royen BJ: Molecular alterations as target for therapy in
metastatic osteosarcoma: A review of literature. Clin Exp
Metastasis. 28:493–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liang D, Chang JR, Chin AJ, Smith A, Kelly
C, Weinberg ES and Ge R: The role of vascular endothelial growth
factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in
zebrafish development. Mech Dev. 108:29–43. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Björndahl MA, Cao R, Burton JB,
Brakenhielm E, Religa P, Galter D, Wu L and Cao Y: Vascular
endothelial growth factor-a promotes peritumoral lymphangiogenesis
and lymphatic metastasis. Cancer Res. 65:9261–9268. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu W, Xu J, Wang M, Wang Q, Bi Y and Han
M: Tumor-derived vascular endothelial growth factor (VEGF)-A
facilitates tumor metastasis through the VEGF-VEGFR1 signaling
pathway. Int J Oncol. 39:1213–1220. 2011.PubMed/NCBI
|
|
27
|
Zimmermann M, Zouhair A, Azria D and
Ozsahin M: The epidermal growth factor receptor (EGFR) in head and
neck cancer: Its role and treatment implications. Radiation Oncol.
1:112006. View Article : Google Scholar
|
|
28
|
Italiano A, Saint-Paul MC, Caroli-Bosc FX,
François E, Bourgeon A, Benchimol D, Gugenheim J and Michiels JF:
Epidermal growth factor receptor (EGFR) status in primary
colorectal tumors correlates with EGFR expression in related
metastatic sites: Biological and clinical implications. Ann Oncol.
16:1503–1507. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Berx G, Raspé E, Christofori G, Thiery JP
and Sleeman JP: Pre-EMTing metastasis? Recapitulation of
morphogenetic processes in cancer. Clin Exp Metastasis. 24:587–597.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meiners S, Brinkmann V, Naundorf H and
Birchmeier W: Role of morphogenetic factors in metastasis of
mammary carcinoma cells. Oncogene. 16:9–20. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu P, Weaver VM and Werb Z: The
extracellular matrix: A dynamic niche in cancer progression. J Cell
Biol. 196:395–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Felding-Habermann B: Integrin adhesion
receptors in tumor metastasis. Clin Exp Metastasis. 20:203–213.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Khanna C, Wan X, Bose S, Cassaday R, Olomu
O, Mendoza A, Yeung C, Gorlick R, Hewitt SM and Helman LJ: The
membrane-cytoskeleton linker ezrin is necessary for osteosarcoma
metastasis. Nat Med. 10:182–186. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wan X, Mendoza A, Khanna C and Helman LJ:
Rapamycin inhibits ezrin-mediated metastatic behavior in a murine
model of osteosarcoma. Cancer Res. 65:2406–2411. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Derynck R, Akhurst RJ and Balmain A:
TGF-beta signaling in tumor suppression and cancer progression. Nat
Genet. 29:117–129. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Candy P, Phillips MR, Redfern AD, Colley
SM, Davidson JA, Stuart LM, Wood BA, Zeps N and Leedman PJ:
Notch-induced transcription factors are predictive of survival and
5-fluorouracil response in colorectal cancer patients. Br J Cancer.
109:1023–1030. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bernardo GM and Keri RA: FOXA1: A
transcription factor with parallel functions in development and
cancer. Biosci Rep. 32:113–130. 2012. View Article : Google Scholar : PubMed/NCBI
|
